Market: NMS |
Currency: USD
Address: 3060 Pegasus Park Drive
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
📈 Forte Biosciences, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$70.00
-
Upside/Downside from Analyst Target:
119.44%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Forte Biosciences, Inc.
| Date | Reported EPS |
|---|
| 2026-03-31 | -1.45 |
| 2025-11-14 | -0.99 |
| 2025-08-14 | -0.96 |
| 2025-05-15 | -1.37 |
| 2024-11-14 | -4.54 |
| 2024-08-14 | -6.75 |
| 2024-05-13 | -4 |
| 2024-03-18 | -1 |
| 2022-11-14 | -4.5 |
| 2022-08-15 | -5.25 |
| 2021-11-08 | -13.5 |
| 2021-08-16 | -10.75 |
| 2021-05-10 | -9 |
| 2021-03-16 | 26 |
| 2020-11-09 | -11.25 |
| 2020-08-10 | -18.52 |
📰 Related News & Research
🔍 View more Reports
